Allogene Therapeutics, Inc. SEC filings ALLO

Allogene Therapeutics, Inc. has 584 filings in SEC EDGAR's recent list, going back to Apr 19, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 2, 2026 (officer or director change). The company's fiscal year ends on December 31.

Allogene Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Sep 2, 2026 Aug 31, 2026
EFFECT Filing Aug 20, 2026 —
S-3 Shelf registration Aug 12, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Shareholder vote results, Other events
Jun 22, 2026 Jun 18, 2026
424B5 Prospectus supplement Jun 22, 2026 —
DEFA14A Additional proxy material May 28, 2026 —
8-K Current report
Officer or director change
May 28, 2026 May 28, 2026
DEFA14A Additional proxy material May 21, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations
May 13, 2026 May 12, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 18, 2026
PRE 14A Preliminary proxy statement Apr 20, 2026 Apr 20, 2026
8-K Current report
Other events
Apr 15, 2026 Apr 14, 2026
424B5 Prospectus supplement Apr 15, 2026 —
424B5 Prospectus supplement Apr 13, 2026 —
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
S-8 Employee stock plan registration Mar 12, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 14, 2025 Sep 26, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
8-K Current report
Other events
Aug 1, 2025 Aug 1, 2025
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 18, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 18, 2025
S-8 Employee stock plan registration Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
8-K Current report
Material agreement
Feb 25, 2025 Feb 19, 2025
8-K Current report
Officer or director change
Jan 29, 2025 Jan 23, 2025
8-K Current report
Other events
Nov 13, 2024 Nov 11, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report Oct 7, 2024 Oct 3, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 10, 2024 Jun 5, 2024
8-K Current report
Material agreement
May 31, 2024 May 24, 2024
8-K Current report
Other events
May 14, 2024 May 13, 2024
424B5 Prospectus supplement May 14, 2024 —
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
EFFECT Filing Apr 25, 2024 —
CORRESP Letter to the SEC Apr 23, 2024 —
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 5, 2024
UPLOAD Letter from the SEC Mar 19, 2024 —
S-8 Employee stock plan registration Mar 14, 2024 —
S-3 Shelf registration Mar 14, 2024 —
10-K Annual report Mar 14, 2024 Dec 31, 2023
POSASR Filing Mar 14, 2024 —
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
10-K/A Amended annual report Mar 14, 2024 Dec 31, 2022
UPLOAD Letter from the SEC Feb 29, 2024 —
CORRESP Letter to the SEC Feb 22, 2024 —
8-K Current report
Restatement
Feb 16, 2024 Feb 14, 2024
8-K Current report
Material agreement
Jan 31, 2024 Jan 25, 2024
8-K Current report
Material agreement, Exit or restructuring costs, Other events
Jan 5, 2024 Jan 3, 2024
UPLOAD Letter from the SEC Dec 28, 2023 —
8-K Current report
Other events
Dec 19, 2023 Dec 9, 2023
CORRESP Letter to the SEC Dec 15, 2023 —
UPLOAD Letter from the SEC Nov 21, 2023 —
424B5 Prospectus supplement Nov 2, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K/A Amended current report
Officer or director change
Oct 17, 2023 Oct 16, 2023
8-K Current report
Officer or director change
Oct 16, 2023 Oct 16, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Other events
Jun 21, 2023 Jun 15, 2023
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 13, 2023
8-K Current report
Officer or director change
Jun 14, 2023 Jun 9, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 3, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
ARS Annual report to shareholders Apr 24, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 24, 2023 —
DEF 14A Proxy statement Apr 24, 2023 —
8-K Current report
Officer or director change
Apr 20, 2023 Apr 18, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Officer or director change
Jan 3, 2023 Dec 27, 2022
8-K Current report
Other events
Nov 29, 2022 Nov 29, 2022
S-3ASR Automatic shelf registration Nov 2, 2022 —
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
8-K Current report
Other events
Oct 6, 2022 Oct 6, 2022
8-K Current report
Other events
Sep 21, 2022 Sep 15, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
SC TO-I/A Filing Jul 20, 2022 —
SC TO-I/A Filing Jul 12, 2022 —
8-K Current report
Officer or director change
Jul 12, 2022 Jul 8, 2022
SC TO-I Filing Jun 21, 2022 —
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 15, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 15, 2022
SC TO-C Filing Apr 14, 2022 —
PRE 14A Preliminary proxy statement Apr 14, 2022 Jun 15, 2022
S-8 Employee stock plan registration Feb 23, 2022 —
10-K Annual report Feb 23, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
8-K Current report
Material agreement, Other events
Dec 15, 2021 Dec 10, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
CT ORDER Filing Oct 25, 2021 —
8-K Current report
Other events
Oct 7, 2021 Oct 7, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Officer or director change
Aug 2, 2021 Jul 30, 2021
8-K Current report
Shareholder vote results
Jun 15, 2021 Jun 10, 2021
8-K Current report
Officer or director change
May 20, 2021 May 18, 2021
8-K Current report
Other events
May 19, 2021 May 19, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 10, 2021
S-8 Employee stock plan registration Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Material agreement
Dec 15, 2020 Dec 14, 2020
8-K Current report
Other events
Dec 7, 2020 Dec 5, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K/A Amended current report
Shareholder vote results
Oct 26, 2020 Jun 5, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Shareholder vote results
Jun 11, 2020 Jun 5, 2020
8-K Current report
Other events
Jun 4, 2020 Jun 1, 2020
424B5 Prospectus supplement Jun 3, 2020 —
424B5 Prospectus supplement Jun 1, 2020 —
8-K Current report
Other events
May 29, 2020 May 29, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Dec 31, 2019
8-K Current report
Other events
Mar 27, 2020 Mar 27, 2020
S-8 Employee stock plan registration Feb 27, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Officer or director change
Dec 20, 2019 Dec 18, 2019
8-K Current report
Material agreement
Nov 5, 2019 Nov 5, 2019
S-3ASR Automatic shelf registration Nov 5, 2019 —
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Shareholder vote results
Jun 10, 2019 Jun 6, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEFA14A Additional proxy material Apr 24, 2019 —
DEF 14A Proxy statement Apr 24, 2019 Jun 6, 2019
8-K Current report
Other events
Apr 10, 2019 Apr 10, 2019
S-8 Employee stock plan registration Mar 8, 2019 —
10-K Annual report Mar 8, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 8, 2019 Mar 8, 2019
8-K Current report
Material agreement
Feb 20, 2019 Feb 19, 2019
8-K Current report
Officer or director change
Dec 13, 2018 Dec 10, 2018
10-Q Quarterly report Nov 21, 2018 Sep 30, 2018
8-K Current report
Material agreement
Oct 29, 2018 Oct 25, 2018
S-8 Employee stock plan registration Oct 24, 2018 —
8-K Current report
Bylaw or fiscal year change, Other events
Oct 15, 2018 Oct 15, 2018
POS462B Filing Oct 15, 2018 —
POS EX Filing Oct 15, 2018 —
424B4 Prospectus Oct 11, 2018 —
CT ORDER Filing Oct 11, 2018 —
EFFECT Filing Oct 10, 2018 —
S-1MEF Form s-1mef Oct 10, 2018 —
CERT Filing Oct 10, 2018 —
8-A12B Filing Oct 5, 2018 —
S-1/A Amended registration statement Oct 5, 2018 —
CORRESP Letter to the SEC Oct 4, 2018 —
CORRESP Letter to the SEC Oct 4, 2018 —
CORRESP Letter to the SEC Oct 2, 2018 —
S-1/A Amended registration statement Oct 2, 2018 —
UPLOAD Letter from the SEC Sep 26, 2018 —
CORRESP Letter to the SEC Sep 26, 2018 —
S-1/A Amended registration statement Sep 17, 2018 —
CORRESP Letter to the SEC Sep 14, 2018 —
S-1 Registration statement Sep 14, 2018 —
UPLOAD Letter from the SEC Sep 11, 2018 —
DRS Filing Aug 10, 2018 —
D Filing Apr 19, 2018 —

Showing 199 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ALLO (Nasdaq)
Fiscal year ends
December 31
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1737287

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.